About i-MED
A timeline of GC i-MED's journey to becoming Korea's leadinghealth screening institution.
2026
2026.02
Awarded Best Brand in Health Screening Medical Institution category — Forbes Korea Best Brand Awards2025
Opened Vietnam Center
2025.12
2025.08
Opened GC I-MED Seoulsup Clinic
Introduced ECG reading AI
assistance solution
2025.01
2024
2024.10
Introduced quantitative
EEG analysis AI solutionDesignated as an Excellent Institution — 4th Cycle (2021–2023) National Health Screening Institution Evaluation
by Ministry of Health and Welfare
2024.04
2021
2021.03
Adopted VUNO AI fundus reading solution (Korea’s 1st innovative medical device); introduced AI-assisted intraocular pressure/fundus & cardiovascular risk prediction solution2020
Awarded Grand Prize — ‘2020 Best Brand Chosen by Consumers’ in Health Screening category (Chosun Ilbo)
2020.10
2020.05
Opened GC I-MED Gangbuk Center
2019
Introduced Selenia Dimensions 3D — digital breast tomosynthesis system
2019.04
2018
2018.03
Group-wide CI rebranding across
all GC affiliates2017
Gangnam Center relocated & expanded
(state-of-the-art facility); introduced MRI
3.0T & MDCT 128ch
(Majestas City, Seocho)
2017.05
2015
2015.10
Gangnam Center relocated & expanded
(state-of-the-art facility); introduced MRI
3.0T & MDCT 128ch
(Majestas City, Seocho)2014
CI rebranding (Greencross Health Promotion Center → Greencross i-MED); opened integrated care center
2014.07
2014.04
CI rebranding (Greencross Health Promotion Center → Greencross i-MED); opened integrated care centerDesignated as a Special Health Examination Institution
2014.03
2013
2013.02
Designated as a Special Health Examination Institution2012
Re-registered as a licensed medical institution for foreign patient attraction
2012.08
2012.06
Launched anticancer immune cell therapy; adopted ImmuCell anti-malignant tumor treatment technology2010
Designated as a delegated institution for vaccination programs
2010.06
2009
2009.09
Designated as a delegated institution for vaccination programsDesignated as a confirmed testing institution for novel influenza (H1N1)
2009.06
2008
2008.07
Achieved simultaneous certification: ISO 9001 Quality Management & ISO 14001 Environmental Management1991
Opened Human Health Screening Center under Green Cross Medical Foundation
1991.10
1982
1982.07
Established Green Cross Bio Science Lab. (Korea’s first commercial lab.)A timeline of GC i-MED's journey to becoming Korea's leadinghealth screening institution.
2026
2026.02
Awarded Best Brand in Health Screening Medical Institution category — Forbes Korea Best Brand Awards2025
Opened Vietnam Center
2025.12
2025.08
Opened GC I-MED Seoulsup Clinic
Introduced ECG reading AI
assistance solution
2025.01
2024
2024.10
Introduced quantitative
EEG analysis AI solutionDesignated as an Excellent Institution — 4th Cycle (2021–2023) National Health Screening Institution Evaluation
by Ministry of Health and Welfare
2024.04
2021
2021.03
Adopted VUNO AI fundus reading solution (Korea’s 1st innovative medical device); introduced AI-assisted intraocular pressure/fundus & cardiovascular risk prediction solution2020
Awarded Grand Prize — ‘2020 Best Brand Chosen by Consumers’ in Health Screening category (Chosun Ilbo)
2020.10
2020.05
Opened GC I-MED Gangbuk Center
2019
Introduced Selenia Dimensions 3D — digital breast tomosynthesis system
2019.04
2018
2018.03
Group-wide CI rebranding across
all GC affiliates2017
Gangnam Center relocated & expanded
(state-of-the-art facility); introduced MRI
3.0T & MDCT 128ch
(Majestas City, Seocho)
2017.05
2015
2015.10
Gangnam Center relocated & expanded
(state-of-the-art facility); introduced MRI
3.0T & MDCT 128ch
(Majestas City, Seocho)2014
CI rebranding (Greencross Health Promotion Center → Greencross i-MED); opened integrated care center
2014.07
2014.04
CI rebranding (Greencross Health Promotion Center → Greencross i-MED); opened integrated care centerDesignated as a Special Health Examination Institution
2014.03
2013
2013.02
Designated as a Special Health Examination Institution2012
Re-registered as a licensed medical institution for foreign patient attraction
2012.08
2012.06
Launched anticancer immune cell therapy; adopted ImmuCell anti-malignant tumor treatment technology2010
Designated as a delegated institution for vaccination programs
2010.06
2009
2009.09
Designated as a delegated institution for vaccination programsDesignated as a confirmed testing institution for novel influenza (H1N1)
2009.06
2008
2008.07
Achieved simultaneous certification: ISO 9001 Quality Management & ISO 14001 Environmental Management1991
Opened Human Health Screening Center under Green Cross Medical Foundation
1991.10
1982
1982.07
Established Green Cross Bio Science Lab. (Korea’s first commercial lab.)